FDA Inspection
Adare Pharmaceuticals SrlAdare Pharmaceuticals Srl – FDA Inspection, Oct 28, 2022
Record Details
This FDA Inspection record concerns Adare Pharmaceuticals Srl, with an inspection on October 28, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Adare Pharmaceuticals Srl
- Inspection Date
- October 28, 2022
- Product Type
- Drugs
View Company Profile
ID · a51f1774-c0ae-4df7-a388-c9f599cf739a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1204801
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Adare Pharmaceuticals Srl
5| Date | Classification | Office | Project area |
|---|---|---|---|
| April 13, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 24, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 30, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 19, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 9, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Adare Pharmaceuticals Srl
- FDA Inspection 1098299 - 2018-04-13
- FDA Inspection 1006241 - 2017-02-24
- FDA Inspection 883317 - 2014-05-30
- FDA Inspection 793805 - 2012-07-19
- FDA Inspection 622477 - 2009-10-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.